Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Exemestane and Kisspeptin Interaction: Synergistic | Peptide Database

Compound Profiles Exemestane Steroidal Aromatase Inhibitor | Irreversible Estrogen Control Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Kisspeptin

KISS1 Gene Product | Reproductive Neuropeptide

Binds to GPR54/KISS1R receptors on hypothalamic GnRH neurons, triggering pulsatile GnRH release, which stimulates pituitary LH/FSH secretion and gonadal steroid production..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Exemestane with Kisspeptin?

Yes, Exemestane and Kisspeptin can generally be taken together. Kisspeptin helps manage estrogen conversion from Exemestane. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Exemestane and Kisspeptin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: estrogenic. Monitor accordingly.

What are the interactions between Exemestane and Kisspeptin?

Kisspeptin helps manage estrogen conversion from Exemestane. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 49% confidence and is inferred from pharmacological mechanism analysis.

How should I time Exemestane and Kisspeptin?

Exemestane has a half-life of ~24 hours and Kisspeptin has a half-life of ~4 minutes (KP-10), ~28-32 minutes (KP-54). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching Ovagen — share findings, ask questions, and learn from real experiences Ovagen is a Khavinson bioregulator tripeptide (EDL) with primary effects on the liver and gastrointestinal tract. Developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it reduces long-term liver fibrosis and protects the GI mucosal layer from antibiotics, environmental toxins, and chemotherapy. Like other bioregulators, Ovagen crosses cell and nuclear membranes to directly regulate DNA transcription patterns with tissue-specific effects. Ovagen works through epigenetic regulation by crossing cell and nuclear membranes to directly regulate DNA structure and transcription patterns. It is transported into cells via POT family transporters (PEPT1, PEPT2) that specifically handle di- and tripeptides, explaining its precise tissue targeting. The peptide has tissue-specific effects on liver and GI tract, reducing fibrosis and protecting mucosal integrity.

Source: peptide-db.com ↗

Research Indications

Reduces body fat by increasing energy expenditure and fat oxidation without reducing food intake. Research shows reversal of diet-induced insulin resistance in mouse models. Addresses multiple components of metabolic syndrome through enhanced energy expenditure. 2024 research shows combining BAM-15 with semaglutide produces stronger metabolic benefits than either alone by countering metabolic adaptation. May help overcome weight loss plateaus by preventing metabolic adaptation/efficiency. Research shows decreased liver triglycerides in treated animals. Improved glucose tolerance observed in research models.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Abaloparatide is administered as a once-daily subcutaneous injection in the periumbilical (around the navel) region of the abdomen. It comes in pre-filled pen devices (Tymlos). Cumulative lifetime use is limited to 2 years due to theoretical osteosarcoma risk observed in rodent studies. A transdermal patch formulation is also in development. Osteoporosis treatment 80 mcg Once daily SubQ (periumbilical abdomen)

Source: peptide-db.com ↗
Side effects

Common Side Effects

Mild gastrointestinal discomfort (nausea, bloating, or stomach upset) with oral doses, particularly at higher dosages taken without food Injection site pain, redness, or mild swelling with injectable administration

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides